Literature DB >> 31501523

Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.

Jia Sun1,2, Jing Yan1, Huai-Yu Qiao1, Fu-Ying Zhao1, Chao Li1, Jing-Yi Jiang1, Bao-Qin Liu1, Xiao-Na Meng1, Hua-Qin Wang3,4.   

Abstract

TRIM family proteins are defined as E3 ubiquitin ligases because of their RING-finger domains. The ubiquitin-like protein interferon-stimulated gene 15 (ISG15) encodes a 15-kDa protein, that is implicated in the posttranslational modification of diverse proteins. Both TRIM29 and ISG15 play both pro-tumoral and anti-tumoral functions in cancer cells derived from different histology. In the current study, we demonstrated that correlation expression of TRIM29 and ISG15 in pancreatic ductal adenocarcinomas (PDACs). The current study demonstrated that TRIM29 knockdown destabilized ISG15 protein via promoting its processing by calpain 3 (CAPN3). Importantly, the current study found that TRIM29 knockdown suppressed cancer stem cell-like features of PDACs, which can be rescued by ISG15 independent of its conjugation function. In addition, the current study demonstrated that extracellular free ISG15 played an important role in maintenance of cancer stem cell-like features of PDACs. Thereby, the current study displayed a novel mechanism by which TRIM29 modulates ISG15 stability via CAPN3-mediated processing, and subsequently extracellular ISG15 maintains the cancer stem cell-like features of PDAC via autocrine mode of action.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31501523     DOI: 10.1038/s41388-019-0992-2

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  49 in total

1.  Cloning of a candidate gene for ataxia-telangiectasia group D.

Authors:  L N Kapp; R B Painter; L C Yu; N van Loon; C W Richard; M R James; D R Cox; J P Murnane
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

2.  TRIM29 suppresses TWIST1 and invasive breast cancer behavior.

Authors:  Lingbao Ai; Wan-Ju Kim; Merve Alpay; Ming Tang; Carolina E Pardo; Shigetsugu Hatakeyama; W Stratford May; Michael P Kladde; Coy D Heldermon; Erin M Siegel; Kevin D Brown
Journal:  Cancer Res       Date:  2014-06-20       Impact factor: 12.701

3.  Tripartite motif-containing 29 as a novel biomarker in non-small cell lung cancer.

Authors:  Xiaoming Song; Chunhai Fu; Xudong Yang; Dongfeng Sun; Xianqi Zhang; Jiandong Zhang
Journal:  Oncol Lett       Date:  2015-08-19       Impact factor: 2.967

4.  Up-regulation of tripartite motif-containing 29 promotes cancer cell proliferation and predicts poor survival in colorectal cancer.

Authors:  Tao Jiang; Hua-mei Tang; Su Lu; Dong-wang Yan; Yin-xue Yang; Zhi-hai Peng
Journal:  Med Oncol       Date:  2013-09-28       Impact factor: 3.064

5.  Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation.

Authors:  G L Mutter; J P Baak; J T Fitzgerald; R Gray; D Neuberg; G A Kust; R Gentleman; S R Gullans; L J Wei; M Wilcox
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

6.  Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.

Authors:  Yoshimasa Kosaka; Hiroshi Inoue; Takahiro Ohmachi; Takeshi Yokoe; Toshifumi Matsumoto; Koshi Mimori; Fumiaki Tanaka; Masahiko Watanabe; Masaki Mori
Journal:  Ann Surg Oncol       Date:  2007-06-28       Impact factor: 5.344

7.  The tripartite motif family identifies cell compartments.

Authors:  A Reymond; G Meroni; A Fantozzi; G Merla; S Cairo; L Luzi; D Riganelli; E Zanaria; S Messali; S Cainarca; A Guffanti; S Minucci; P G Pelicci; A Ballabio
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

8.  TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.

Authors:  Shu-Tao Tan; Sheng-Ye Liu; Bin Wu
Journal:  Cancer Res Treat       Date:  2016-03-11       Impact factor: 4.679

9.  TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.

Authors:  Rui Xu; Jingye Hu; Tiansong Zhang; Chao Jiang; Hui-Yun Wang
Journal:  Oncotarget       Date:  2016-05-10

10.  Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.

Authors:  Xiao-Min Zhou; Rui Sun; Dong-Hua Luo; Jian Sun; Mei-Yin Zhang; Meng-He Wang; Yang Yang; Hui-Yun Wang; Shi-Juan Mai
Journal:  Oncotarget       Date:  2016-03-22
View more
  10 in total

1.  Comprehensive analysis of prognostic value and immune infiltration of calpains in pancreatic cancer.

Authors:  Chuan Lan; Haoyou Tang; Sheng Liu; Lin Ma; Jianshui Li; Xi Wang; Yifu Hou
Journal:  J Gastrointest Oncol       Date:  2021-12

Review 2.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

3.  ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.

Authors:  Qi Zhang; Jiamei Wang; Huaiyu Qiao; Lingyue Huyan; Baoqin Liu; Chao Li; Jingyi Jiang; Fuying Zhao; Huaqin Wang; Jing Yan
Journal:  J Cell Mol Med       Date:  2021-04-02       Impact factor: 5.310

Review 4.  TRIM29 in Cutaneous Squamous Cell Carcinoma.

Authors:  Che-Yuan Hsu; Teruki Yanagi; Hideyuki Ujiie
Journal:  Front Med (Lausanne)       Date:  2021-12-20

5.  CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.

Authors:  Tao Jiang; Hongyu Wang; Lianyu Liu; Hu Song; Yi Zhang; Jiaqi Wang; Lei Liu; Teng Xu; Ruizhi Fan; Yixin Xu; Shuai Wang; Linsen Shi; Li Zheng; Renhao Wang; Jun Song
Journal:  Mol Cancer       Date:  2021-12-18       Impact factor: 27.401

6.  WBSCR22 and TRMT112 synergistically suppress cell proliferation, invasion and tumorigenesis in pancreatic cancer via transcriptional regulation of ISG15.

Authors:  Aamir Ali Khan; Hua Huang; Yue Zhao; Huan Li; Ruining Pan; Sijia Wang; Xinhui Liu
Journal:  Int J Oncol       Date:  2022-01-28       Impact factor: 5.650

7.  Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma.

Authors:  Duo Zuo; Yongzi Chen; Xinwei Zhang; Zhuozhi Wang; Wenna Jiang; Fan Tang; Runfen Cheng; Yi Sun; Lu Sun; Li Ren; Rui Liu
Journal:  Cancer Biol Med       Date:  2021-08-17       Impact factor: 5.347

8.  ISG15 as a prognostic biomarker in solitary fibrous tumour.

Authors:  Jose L Mondaza-Hernandez; David S Moura; María Lopez-Alvarez; Paloma Sanchez-Bustos; Elena Blanco-Alcaina; Carolina Castilla-Ramirez; Paola Collini; Jose Merino-Garcia; Jorge Zamora; Jaime Carrillo-Garcia; Roberta Maestro; Nadia Hindi; Jesus Garcia-Foncillas; Javier Martin-Broto
Journal:  Cell Mol Life Sci       Date:  2022-07-21       Impact factor: 9.207

9.  E3 Ubiquitin Ligase CHIP Inhibits the Interaction between Hsp90β and MAST1 to Repress Radiation Resistance in Non-Small-Cell Lung Cancer Stem Cells.

Authors:  Bo Tan; Jingwei Zhang; Wen Wang; Haibo Ma; Yuanyuan Yang
Journal:  Stem Cells Int       Date:  2022-09-20       Impact factor: 5.131

10.  TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT-GSK-3β-β-Catenin Signaling Pathway.

Authors:  Shiyu Chen; Zhiwei He; Changhao Zhu; Yanqing Liu; Lin Li; Lu Deng; Jun Wang; Chao Yu; Chengyi Sun
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.